You can buy or sell Advaxis and other stocks, options, and ETFs commission-free!
Advaxis, Inc. Common Stock, also called Advaxis, is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. The listed name for ADXS is Advaxis, Inc. Common Stock.
Kenneth A. Berlin
Princeton, New Jersey
52 Week High
52 Week Low
Why These 3 Pharma Stocks Are Moving Today
Alnylam Pharmaceuticals (NASDAQ: ALNY) shares are trading higher on Tuesday after the company announced its OXLUMO injection has received FDA approval for the t
— per share
Expected Dec 17, Pre-Market